Elevance Health (NYSE: ELV) continues to point to its provider capabilities – which include home-based care services – as a strategic priority. The company has partnered with the private equity firm Clayton, Dubilier & Rice (CD&R) on a primary care initiative that will bring together Carelon Health – Elevance Health’s provider arm – and apree […]
Clayton Dubilier & Rice
Thanks to impactful, large-scale transactions over the last decade, the collective face of home-based care has changed forever. Traditional providers in both home health care and personal home care have merged. Payers became involved in the home-based care space like never before. Of late, retailers have too. But it’s often easy to forget how the […]
Home-based care dealmaking experts believe that value-based care will be an overarching theme in M&A over the course of the next few years. They also believe that the shift to value-based care is still in the very early stages. “I think it’s pretty clear that that’s where we have to go and that’s where payers […]
Gentiva – the company comprised of the hospice and personal home care assets of what was formerly Kindred at Home – has agreed to acquire ProMedica’s Heartland home health and hospice assets for $710 million. Led by the former CEO of Kindred, David Causby, Gentiva is backed by both Humana Inc. (NYSE: HUM) and the […]
The public perception of private equity (PE) firms is not always rosy, but for health care providers – especially founder-led ones – they can sometimes be a proverbial knight in shining armor. Innovation, expansion and financial freedom can all be achieved through the backing of a PE firm. Like most things in the world, home-based […]
Humana Inc. (NYSE: HUM) announced Thursday that it has completed its divestiture of Kindred at Home’s hospice and personal care divisions. Clayton, Dubilier & Rice (CD&R) has acquired a majority interest in those assets, or 60%. Now that the deal is closed, the hospice and personal care assets will be restructured into a standalone company. […]
Humana Inc. (NYSE: HUM) has agreed to sell 60% of its hospice and personal care assets from Kindred at Home to the private equity firm Clayton Dubilier & Rice (CDR). The deal is expected to close in the third quarter of this year. And its surrounding details are of interest for multiple reasons. The first […]
Subscribe
Receive industry updates and breaking news from HHCN